Cargando…

Prognostic Value of [18F]-Fluoro-Deoxy-Glucose PET/CT, S100 or MIA for Assessment of Cancer-Associated Mortality in Patients with High Risk Melanoma

PURPOSE: To assess the prognostic value of FDG PET/CT compared to the tumor markers S100B and melanoma inhibitory activity (MIA) in patients with high risk melanoma. METHODS: Retrospective study in 125 consecutive patients with high risk melanoma that underwent FDG PET/CT for re-staging. Diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Essler, Markus, Link, Anna, Belloni, Benedetta, Mirceva, Vesna, Souvatzoglou, Michael, Thaler, Markus, Haller, Bernhard, Hein, Ruediger, Krause, Bernd J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173468/ https://www.ncbi.nlm.nih.gov/pubmed/21935432 http://dx.doi.org/10.1371/journal.pone.0024632

Ejemplares similares

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010)

6-Deoxy-6-fluoro-d-galactose
por: Jenkinson, Sarah F., et al.
Publicado: (2010)

1-Deoxy-1-fluoro-l-galactitol
por: Jenkinson, Sarah F., et al.
Publicado: (2010)

Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose
por: Penna, Patricia Sola, et al.
Publicado: (2023)

Optimal 2-[(18)F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
por: Horsager, Jacob, et al.
Publicado: (2016)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
por: Plöckinger, U., et al.
Publicado: (2018)

2-Deoxy-2-fluoro-d-glucose metabolism in Arabidopsis thaliana
por: Fatangare, Amol, et al.
Publicado: (2015)

PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[(18)F]fluoro-6-deoxy-D-fructose
por: Boyle, Amanda J., et al.
Publicado: (2022)

Lesbia mía /
por: Priante, Antonio, 1939-
Publicado: (1992)

LunaMía /
por: Coria, Neftalí
Publicado: (1994)

Patria mía
por: Pound, Ezra 1885-1972
Publicado: (1985)

Patria mía /
por: Pound, Ezra, 1885-1972
Publicado: (1971)

Tierra mía
por: Aguirre Beltrán, Francisco, 1899-

Queridas mías
por: Lispector, Clarice
Publicado: (2010)

Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET
por: Beer, Ambros J., et al.
Publicado: (2016)

Kikuchi-Fujimoto disease mimicking malignant lymphoma with 2-[(18)F]fluoro-2-deoxy-D-glucose PET/CT in children
por: Kim, Ji Eun, et al.
Publicado: (2014)

Clinical Utility of (18)F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma
por: Cowzer, Darren, et al.
Publicado: (2023)

Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases
por: Veronesi, G, et al.
Publicado: (2002)

Increased FluoroDeoxyGlucose (FDG) Avidity Following COVID-19 Vaccination
por: Nassar, Mo’ath, et al.
Publicado: (2022)

To Mia or not to Mia: stepwise evolution of the mitochondrial intermembrane space disulfide relay
por: Carrie, Chris, et al.
Publicado: (2017)

Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[(18)F]-Fluoro-L-Thymidine ([(18)F]FLT) Positron Emission Tomography (PET)
por: Ullrich, Roland T., et al.
Publicado: (2008)

Vida mía : Tango canción
por: Fresedo, Emilio
Publicado: (1945)

Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16α-18F-fluoro-17β-estradiol PET
por: Yoshida, Yoshio, et al.
Publicado: (2009)

Assessment of diffuse Lewy body disease by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET)
por: Mirzaei, Siroos, et al.
Publicado: (2003)

Metabolic liver function in humans measured by 2-(18)F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential
por: Bak-Fredslund, Kirstine P., et al.
Publicado: (2017)

Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
por: Seiler, Stefanie M. F., et al.
Publicado: (2015)

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
por: Miele, Evelina, et al.
Publicado: (2008)

Estas páginas mías /
por: Arreola, Juan José
Publicado: (2018)

Estas páginas mías /
por: Arreola, Juan José
Publicado: (2000)

Antigua vida mía
por: Serrano, Marcela, 1951-
Publicado: (1995)

Estas páginas mías /
por: Arreola, Juan José
Publicado: (1985)

La Tierra Mía/
por: Carmen Leñero

Antigua vida mía
por: Serrano, Marcela, 1951-

Importance of diffuse versus focal F-18 fluoro-deoxy-glucose uptake in oesophagus
por: Santhosh, Sampath, et al.
Publicado: (2011)

Opportunities for 2-[(18)F] Fluoro-2-Deoxy-D-Glucose PET/CT in Cervical-Vaginal Neuroendocrine Carcinoma: Case Series and Literature Review
por: Lin, Yin, et al.
Publicado: (2012)

Is 2-deoxy-2-[(18)F]fluoro-D-glucose PET/CT acquisition from the upper thigh to the vertex of skull useful in oncological patients?
por: Salvatore, B., et al.
Publicado: (2014)

Dynamic 2-deoxy-2[18F] fluoro-D-glucose PET/MRI in human renal allotransplant patients undergoing acute kidney injury
por: Pajenda, Sahra, et al.
Publicado: (2020)

[(18)F]2-Fluoro-2-deoxy-sorbitol PET Imaging for Quantitative Monitoring of Enhanced Blood-Brain Barrier Permeability Induced by Focused Ultrasound
por: Hugon, Gaëlle, et al.
Publicado: (2021)

18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol
por: Jena, Rahul, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b20hsqv7ajq1rqd2b14qubecke